TROY, Mich. / Sep 10, 2025 / Business Wire / ZIVO Bioscience, Inc. (OTCQB: ZIVO) , a biotech and agtech R&D company engaged in the development of therapeutic and nutritional products derived from proprietary algal cultures, today issued the following letter to shareholders from Chairman, President and Chief Executive Officer John B. Payne. Dear Fellow Shareholders, I am pleased to provide you with this important update on... Read More